Testing pulsed electric field ablation for small lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have non-small cell lung cancer with tumors that are 3 cm or smaller and no more than 3 tumors.
- You are well enough to undergo anesthesia and the ablation procedure.
- You do not have serious bleeding problems or take blood thinners that cannot be stopped.
- You do not have severe heart or lung conditions that would make the procedure unsafe.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called pulsed electric field therapy for people with advanced lung cancer (stage III or IV) that has not responded to first-line immunotherapy. It uses targeted electrical pulses to destroy tumor cells, and may be an option for those who still have other measurable tumors.
This trial tests a device that sends low-energy electrical fields (called Tumor Treating Fields) to the lung tumor before surgery. The goal is to see if it can help shrink the tumor and improve surgical outcomes.
This trial tests combining tumor ablation with the immunotherapy drug tislelizumab and chemotherapy before surgery for people with stage II–IIIB non-small cell lung cancer. The goal is to see if this combination helps remove the cancer more effectively.
This trial tests a new device that uses pulses to destroy small lung tumors. It is for people who have 3 or fewer lung nodules, cannot have surgery, or choose not to.
This trial compares two types of radiofrequency ablation (a heat-based treatment) for early-stage lung cancer that is located in the outer parts of the lung. One approach uses a needle through the chest wall, the other uses a bronchoscope through the airways. The goal is to see which works better for people who cannot have surgery.
This trial tests a new treatment called pulsed electric field (PEF) therapy for people with advanced or unresectable esophageal squamous cell carcinoma. PEF uses short electrical pulses to target and destroy cancer cells. This study is for patients who cannot have surgery or standard treatments, and looks at how safe and effective this therapy is.
Hear when a new NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.